unidentified cachexia patients in the oncologic setting cachexia ufo s do exist

n/

Management of abdominal sepsis - A paradigm shift?

Peer reviewe

Intra-abdominal hypertension and abdominal compartment syndrome in pancreatitis, paediatrics, and trauma

Peer reviewe

The Emerging International Identity of the European Union. Some Preliminary Observations

Item does not contain fulltex

The European Union's Emerging International Identity. Views from the global arena

Item does not contain fulltextXVII, 260 p

Augmented renal clearance and therapeutic monitoring of β-lactams

Successful application of antibacterial therapy in the critically ill requires an appreciation of the complex interaction between the host, the causative pathogen and the chosen pharmaceutical. A pathophysiological change in the intensive care unit (ICU) patient challenging the 'one dose fits all' concept includes augmented renal clearance (ARC), defined as a creatinine clearance (CL) of =130 mL/min. Ideally, CL values should be obtained by a timed measured collection of urine, with plasma and urine creatinine levels. Increased renal clearance of antibiotics also occurs in the ICU patient and therefore β-lactam antibiotic exposure in the critically ill could easily lead to trough drug concentrations below therapeutic ranges. One way to document and alter drug levels is via therapeutic drug monitoring (TDM). The interactions of ARC and β-lactam TDM are further explored in this article in specific reference to a concomitant article in this issue of the journal